Figure 2.

Therapeutics considered for the treatment of anhedonia by physicians. (A) Drug classes that physicians considered prescribing to treat anhedonia in MDD patients. (B) Physicians’ perceived level of satisfaction towards the different pharmaceutical treatment classes for anhedonia treatment on a scale of 1–9, where 1=least satisfied and 9=most satisfied. ^aDrug class HCP considers prescribing to treat MDD-ANH. ^bLevel of satisfaction with pharmaceutical treatment classes (scale 1–9, 1-extremely dissatisfied, 9-extremely satisfied).

Abbreviations: ANH, anhedonia; MDD, major depressive disorder; SD, standard deviation; DNRIs, Dopamine norepinephrine reuptake inhibitors; SNRIs, Serotonin-norepinephrine reuptake inhibitors; SSRI, Selective serotonin reuptake inhibitors; TCA, Tricyclic antidepressants; TeCA, Tetracyclic antidepressants.